You need to sign in or sign up before continuing.
Arch Intern Med
-
Randomized Controlled Trial Clinical Trial
The impact of informed consent on patient interest in prostate-specific antigen screening.
Because of the many uncertainties surrounding screening for prostate cancer, authorities recommend that patients be involved in the screening decision. ⋯ Among primary care patients of predominantly lower socioeconomic status, those who received informed consent were significantly less interested in PSA screening than those who did not. For physicians who offer the PSA as a screening test, this finding highlights the importance of apprising patients of the associated benefits, burdens, and uncertainties and allowing them to participate in the screening decision.